Commentary on peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
Mayer
Emeran A
EA
Center for Neurovisceral Sciences and Women's Health, Department of Medicine, Physiology, and Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. emayer@ucla.edu
D000285:Administration, Rectal; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use; D002490:Central Nervous System / Q000503:physiopathology*; D002908:Chronic Disease; D006801:Humans; D006930:Hyperalgesia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D043183:Irritable Bowel Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology*; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D017933:Peripheral Nervous System / Q000503:physiopathology*
D000779:Anesthetics, Local; D008012:Lidocaine